Internal medicine

Pathology

Biochemical recurrence

Prostate cancer

Biology

Cancer

Oncology

Tissue microarray

Immunohistochemistry

Prostate

Prostatectomy

Stroma

Cohort

Medicine

Journal of Personalized Medicine

Tumor-to-stroma ratio (TSR) is a prognostic factor that expresses the relative amounts of tumor and intratumoral stroma. In this study, its clinical and molecular relevance was evaluated in prostate cancer (PCa). The feasibility of automated quantification was tested in digital scans of tissue microarrays containing 128 primary tumors from 72 PCa patients stained immunohistochemically for epithelial cell adhesion molecule (EpCAM), followed by validation in a cohort of 310 primary tumors from 209 PCa patients. In order to investigate the gene expression differences between tumors with low and high TSR, we applied multigene expression analysis (nCounter

Low Tumor-to-Stroma Ratio Reflects Protective Role of Stroma against Prostate Cancer Progression